May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Carbon Dioxide Inhibits Retinal Angiogenesis via NO–mediated Downregulation of the Prostaglandin Receptor EP3
Author Affiliations & Notes
  • D. Checchin
    Depts. of Pediatrics, Ophthalmology & Pharmacology, Research Ctr/Hosp Ste Justine, Montreal, PQ, Canada
    Dept. of Pharmacology & Therapeutics, McGill University, Montreal, PQ, Canada
  • F. Sennlaub
    Depts. of Pediatrics, Ophthalmology & Pharmacology, Research Ctr/Hosp Ste Justine, Montreal, PQ, Canada
  • M.H. Beauchamp
    Depts. of Pediatrics, Ophthalmology & Pharmacology, Research Ctr/Hosp Ste Justine, Montreal, PQ, Canada
  • S. Chemtob
    Depts. of Pediatrics, Ophthalmology & Pharmacology, Research Ctr/Hosp Ste Justine, Montreal, PQ, Canada
    Dept. of Pharmacology & Therapeutics, McGill University, Montreal, PQ, Canada
  • Footnotes
    Commercial Relationships  D. Checchin, None; F. Sennlaub, None; M.H. Beauchamp, None; S. Chemtob, None.
  • Footnotes
    Support  NSERC, March of Dimes
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1890. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. Checchin, F. Sennlaub, M.H. Beauchamp, S. Chemtob; Carbon Dioxide Inhibits Retinal Angiogenesis via NO–mediated Downregulation of the Prostaglandin Receptor EP3 . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1890.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Epidemiologic studies and animal models have revealed that hypercapnia impairs normal vascular development, yet little is known about its mechanisms. Given that any instance of ischemia is by physiological consequence accompanied by a local tissue hypercapnia, such mechanisms would provide insight into several ischemic retinopathies (e.g. retinopathy of prematurity, diabetic retinopathy, etc.), as well as into ischemia–related conditions in general. Recently, hypercapnia has been shown to elicit increased expression and activation of endothelial NO synthase (eNOS). Therefore, we further investigated how CO2 and NO may contribute to retinal vascular impairment. Methods: Rat pups were exposed from birth until day 6 to 10% CO2. Following exposure, the vessels were stained and the degree of vascularization quantified. Western blot analyses for NOSs, the angiogenic prostaglandin receptor, EP3, and an EP3 transcription factor, NFkappaB, were performed, as was immunohistochemistry on retinal sections for NOS localization. Intraocular injections of either the non–selective NOS inhibitor, L–NAME, or the selective EP3 agonist, M&B28767, were used to examine their roles in hypercapnia–induced vasoattenuation. Lastly, retinas were cultured as ex vivo explants under control or hypercapnic conditions (5% and 10% CO2, respectively) to determine the effects of hypercapnia independent of hemodynamics. Results: Hypercapnia led to increases in eNOS with L–NAME acting to protect the retina from the hypercapnia–induced arrest in vessel development. Hypercapnia resulted in a decrease of nuclear NFkappaB, and a downregulation of EP3 which was inhibited by L–NAME. Stimulation of EP3 diminished the deleterious effects of hypercapnia. Furthermore, ex vivo explants illustrated that hypercapnia can also have detrimental effects on EC survival completely independent of its effects on hemodynamics. Conclusions: This work provides novel insight into the genesis of ischemic retinopathies by describing a novel pathway of CO2/NO–mediated inhibition of retinal angiogenesis via NFkappaB–related downregulation of the angiogenic prostaglandin receptor, EP3. Moreover, these results unveil the adverse effects of hypercapnia on EC survival completely independent of hemodynamics.

Keywords: ischemia • eicosanoids • nitric oxide 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×